United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Report 2018

March 2018 | 98 pages | ID: U236B104B55QEN
QYResearch

Abstracts

In this report, the United States Drugs for Vancomycin-Resistant Enterococcus Faecium market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Drugs for Vancomycin-Resistant Enterococcus Faecium in these regions, from 2013 to 2025 (forecast).

United States Drugs for Vancomycin-Resistant Enterococcus Faecium market competition by top manufacturers/players, with Drugs for Vancomycin-Resistant Enterococcus Faecium sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Alchemia Limited
• Alvogen
• Aphios Corporation
• Cellceutix Corporation
• Enanta Pharmaceuticals
• Helix BioMedix
• LegoChem Biosciences
• Lytix Biopharma
• MGB Biopharma Limited
• Microbiotix

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Daptomycin
• Linezolid
• Quinupristin/dalfopristin
• Ampicillin
• Chloramphenicol
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Report 2018

1 DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM OVERVIEW

1.1 Product Overview and Scope of Drugs for Vancomycin-Resistant Enterococcus Faecium
1.2 Classification of Drugs for Vancomycin-Resistant Enterococcus Faecium by Product Category
  1.2.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Daptomycin
  1.2.4 Linezolid
  1.2.5 Quinupristin/dalfopristin
  1.2.6 Ampicillin
  1.2.7 Chloramphenicol
  1.2.8 Others
1.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Application/End Users
  1.3.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Region
  1.4.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Drugs for Vancomycin-Resistant Enterococcus Faecium Status and Prospect (2013-2025)
  1.4.3 Southwest Drugs for Vancomycin-Resistant Enterococcus Faecium Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Drugs for Vancomycin-Resistant Enterococcus Faecium Status and Prospect (2013-2025)
  1.4.5 New England Drugs for Vancomycin-Resistant Enterococcus Faecium Status and Prospect (2013-2025)
  1.4.6 The South Drugs for Vancomycin-Resistant Enterococcus Faecium Status and Prospect (2013-2025)
  1.4.7 The Midwest Drugs for Vancomycin-Resistant Enterococcus Faecium Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Drugs for Vancomycin-Resistant Enterococcus Faecium (2013-2025)
  1.5.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2013-2025)
  1.5.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2013-2025)

2 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Average Price by Players/Suppliers (2013-2018)
2.4 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Competitive Situation and Trends
  2.4.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Concentration Rate
  2.4.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Region (2013-2018)
3.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Region (2013-2018)
3.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Region (2013-2018)

4 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Type (2013-2018)
4.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Type (2013-2018)
4.4 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Type (2013-2018)

5 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Application (2013-2018)
5.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alchemia Limited
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Alvogen
  6.2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Aphios Corporation
  6.3.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Cellceutix Corporation
  6.4.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Enanta Pharmaceuticals
  6.5.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Helix BioMedix
  6.6.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 LegoChem Biosciences
  6.7.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Lytix Biopharma
  6.8.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 MGB Biopharma Limited
  6.9.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Microbiotix
  6.10.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MANUFACTURING COST ANALYSIS

7.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Vancomycin-Resistant Enterococcus Faecium Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Forecast by Type (2018-2025)
11.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Forecast by Application (2018-2025)
11.4 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Drugs for Vancomycin-Resistant Enterococcus Faecium
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (K Pcs) by Type (2013-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Market Share by Type (Product Category) in 2017
Figure Daptomycin Product Picture
Figure Linezolid Product Picture
Figure Quinupristin/dalfopristin Product Picture
Figure Ampicillin Product Picture
Figure Chloramphenicol Product Picture
Figure Others Product Picture
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Drugs for Vancomycin-Resistant Enterococcus Faecium by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (Million USD) by Region (2013-2025)
Figure The West Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Players/Suppliers
Figure 2017 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Players/Suppliers
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Players/Suppliers
Figure 2017 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Players/Suppliers
Table United States Market Drugs for Vancomycin-Resistant Enterococcus Faecium Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Drugs for Vancomycin-Resistant Enterococcus Faecium Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share of Top 3 Players/Suppliers
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Drugs for Vancomycin-Resistant Enterococcus Faecium Product Category
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs) by Region (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Region (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Region (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Region in 2017
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Region (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Region (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Region in 2017
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Price (USD/Pcs) by Region (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs) by Type (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Type (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Type (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type in 2017
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Drugs for Vancomycin-Resistant Enterococcus Faecium by Type (2013-2018)
Figure Revenue Market Share of Drugs for Vancomycin-Resistant Enterococcus Faecium by Type in 2017
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Price (USD/Pcs) by Types (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Type (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs) by Application (2013-2018)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application in 2017
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Application (2013-2018)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Application (2013-2018)
Table Alchemia Limited Basic Information List
Table Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Alvogen Basic Information List
Table Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Aphios Corporation Basic Information List
Table Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Cellceutix Corporation Basic Information List
Table Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Enanta Pharmaceuticals Basic Information List
Table Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Helix BioMedix Basic Information List
Table Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table LegoChem Biosciences Basic Information List
Table LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Lytix Biopharma Basic Information List
Table Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table MGB Biopharma Limited Basic Information List
Table MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Microbiotix Basic Information List
Table Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate (2013-2018)
Figure Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share in United States (2013-2018)
Figure Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vancomycin-Resistant Enterococcus Faecium
Figure Manufacturing Process Analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium
Figure Drugs for Vancomycin-Resistant Enterococcus Faecium Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vancomycin-Resistant Enterococcus Faecium Major Players/Suppliers in 2017
Table Major Buyers of Drugs for Vancomycin-Resistant Enterococcus Faecium
Table Distributors/Traders List
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Share Forecast by Region (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Share Forecast by Region (2018-2025)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources